Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Celgene
Seagen Inc.
Hoffmann-La Roche
Takeda
CTI BioPharma
CTI BioPharma
Fred Hutchinson Cancer Center
Seagen Inc.
Seagen Inc.
M.D. Anderson Cancer Center
Seagen Inc.
Stanford University
M.D. Anderson Cancer Center
Baylor College of Medicine
University of Chicago
Ariad Pharmaceuticals
M.D. Anderson Cancer Center